ArticleBrain pathology (Zurich, Switzerland)2014

MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target PAPST1.

Qing-Fu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.